|Ordering and shipment information
|T-activated® proteins:||IE-1 (code: 12311001), pp65 (code: 12311002), EBNA3A (code: 12312002)
||500 µl per vial
||ELISpot, FACS, ELISA
||worldwide cooled shipping
||+49 941 630 9197-0
||Approximately 1-3 days
||250.00 € per vial
|Note: prices do not include shipping and freight costs, charges, taxes or custom duties
Advantages of T-activated® proteins
In contrast to peptides and unmodified proteins, T-activated® proteins (formulated with Lophius patented T-activation® buffer) are processed and presented via the exogenous (MHC-II) and endogenous (MHC-I; cross-presentation) pathways by functional antigen-presenting cells (APC), thus mimicking a natural infection.
In addition, T-activated® proteins result in a more efficient and HLA antigen-independent stimulation of a broad spectrum of clinically-relevant subpopulations of antigen-reactive effector cells (CD4+ and CD8+ T cells, NK and NKT-like cells).
- Recombinant T-activated® proteins for effective in vitro stimulation of antigen-specific effector cells including CD4+ T cells, CD8+ T cells, NK cells and NKT-like cells
- Processed by APC via the exogenous and endogenous antigen-presentation pathways
- For epitope-loading on MHC-II as well as MHC-I molecules by cross-presentation
- Actively processed by APC leading to a physiological and comprehensive stimulation of antigen-specific effector cells